Skip to main content

Table 3 Neuropsychological tests values at baseline

From: A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects

Test

Placeboa

Interferon beta 1aa

Pvalue

ADAS-Cogb

19.81 ± 6.14

18.34 ± 7.85

0.34

MMSEc

22.93 ± 1.78

23.45 ± 2.13

0.41

ADAS-NonCogd

6.06 ± 5.0

4.36 ± 4.12

0.30

PSMSe

6.4 ± 0.91

6.42 ± 1.01

0.98

GDSf

10.66 ± 6.53

10.10 ± 6.12

0.79

Global DSg

2.86 ± 0.74

3.0 ± 0.47

0.50

IADLh

6.2 ± 1.56

6.1 ± 1.44

0.68

  1. aValues are expressed as means ± SD. bADAS-cog, Alzheimer’s Disease Assessment Scale-cognitive subscale; cMMSE, Mini Mental State Examination; dADAS-Non-Cog, Alzheimer’s Disease Assessment Scale-Non-Cognitive Section; ePSMS, Physical Self-Maintenance Scale; fGDS, Geriatric Depression Scale; Global, gGlobal Deterioration Scale (DS) for Assessment of Primary Degenerative Dementia; hIADL, Instrumental Activities of Daily Living Scale.
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094